FDA NDC Directory · JSON-LD · Markdown

ZYNYZ

NDC 50881-006 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameretifanlimab-dlwr
Labeler / ManufacturerIncyte Corporation
Marketing categoryBiologic License Application · App BLA761334
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsRETIFANLIMAB (25 mg/mL)
Marketing started20230322
Package count1

External sources

Source: openFDA. Public-domain (CC0).